AndroGel, Testosterone Therapy Lawsuits Filed Over Heart Risk

February 4, 2014 Last Updated on 03/24/2015

Comments |

At A Glance

This Alert Affects:
Men who experienced a heart attack, stroke or other complications after using prescription testosterone therapies.
What's the Problem?
It is believed that prescription testosterone may increase the risk of heart problems in older men.
Injuries:
Blood clots, stroke, ischemic stroke, high blood pressure, heart attack and death.
FDA Warning:
In March 2015, the FDA announced that all testosterone replacement therapies must have their labels updated to warn patients about the risk of suffering heart attacks and strokes when using the prescriptions. The label update was prompted by several recent studies that suggested these therapies were linked to various heart problems.
What is AndroGel?
AndroGel is a prescription gel medication used to treat low levels of testosterone, also known as "Low T." Testosterone therapies can also come in the form of a patch or injection.
Are Any Other Products Affected?
Testosterone therapies are also sold as Axiron, Fortesta, Striant, Delatestryl, Testopel, Androderm, Bio-T-Gel, Depo-Testosterone, and Testim.
Type of Lawsuit:
Mass Tort